Nature
| [0004]
|
N. Eng. J. Med.
| [0004]
|
Synthesis of 1-Benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole Analogues as Novel Antiplatelet Agents
| [0005]
|
Selective Inhibition of Protease-activated Receptor 4-dependent Platelet Activation by YD-3
| [0005]
|
Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives
| [0005]
|
Remington: The Science and Practice of Pharmacy
| [0094]
|
Medicine
| [0120]
|
N. Engl. J. Med.
| [0120]
|
JAMA
| [0120]
|
Remington: The Science and Practice of Pharmacy
| [0121]
|
ique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib
| [0131]
|
Thrombin receptor antagonists
| [0135]
|
Nonpeptide factor Xa inhibitors: II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis
| [0144]
|
The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys
| [0144]
|
Greene's Protective Groups In Organic Synthesis
| [0148]
[0161]
|